Using Knowledge Translation to Accelerate the Implementation of Medical Abortion in Primary Care

Dec 4, 2017 - 12:00pm to 1:00pm
700-828 W. 10 Ave., VGH Research Pavilion
Sarah Munro

Mifepristone, the "gold standard" for medical abortion, was made available in Canada in January 2017. This innovation has the potential to decrease inequities in access to safe, high-quality abortion care, particularly for rural and remote populations. However, Health Canada approved mifepristone with a number of extraordinary regulatory restrictions - barriers that have impeded the uptake of medical abortion in other high-income countries. To mitigate these potential barriers and accelerate facilitators in Canada, we are conducting a multi-year, national, mixed methods implementation study that explores the effect of knowledge translation strategies on implementation of mifepristone in primary care. This session will provide an overview of the study findings to date.
Learning objectives:

  • Introduce the evidence-to-practice gap for implementation of mifepristone
  • Describe survey and interview findings from year one of the national Mifepristone Implementation Study
  • Discuss practical implications of using knowledge translation to effect policy change